PT - JOURNAL ARTICLE AU - Brkić, Diandra AU - Ng-Cordell, Elise AU - O’Brien, Sinéad AU - Martin, Jessica AU - Scerif, Gaia AU - Astle, Duncan AU - Baker, Kate TI - FarmApp: a new cognitive assessment method for young people with intellectual disability AID - 10.1101/2020.12.02.20242677 DP - 2020 Jan 01 TA - medRxiv PG - 2020.12.02.20242677 4099 - http://medrxiv.org/content/early/2020/12/04/2020.12.02.20242677.short 4100 - http://medrxiv.org/content/early/2020/12/04/2020.12.02.20242677.full AB - Background A major challenge when investigating intellectual disability (ID) is the selection of assessment tools that are sensitive to cognitive diversity within the ID population. This study introduces a new touchscreen-based method, FarmApp, which aims to measure competence in relatively low-level cognitive processes (selective attention, short-term visuospatial memory, longer-term recognition memory) which contribute to complex aspects of learning and behaviour.Methods Here we describe the FarmApp design, testing and analysis procedures. We report the feasibility and validity of the method, and demonstrate its utility for measuring change over time, and for comparing groups defined by aetiology.Results We found that FarmApp can be completed by a higher proportion of young people with ID than traditional psychometric tests. FarmApp performance correlates with standardised neuropsychological tests of attention and working memory, and with questionnaire measures of ADHD-relevant behavioural difficulties. Individual performance slopes over a two-week period correlate with general ability and behavioural difficulties, indicating that FarmApp is sensitive to meaningful dynamic variation in cognitive performance. Finally, we compared the FarmApp performance of two groups of young people with ID, defined by the physiological function of ID-associated genetic variants (functional network groups: chromatin-related and synaptic-related), and found that groups differ on attention parameters but not on memory ones.Conclusion FarmApp is a feasible, valid and useful alternative to traditional neuropsychological tests. It can increase access to cognitive assessment for individuals with ID. It adds the opportunity to monitor variation in performance over time and determine capacity to acquire task competence in addition to baseline ability. Our comparison between functional network groups supports the proposal that cognitive processes contributing to ID are differentially influenced by specific genetic aetiologies. In summary, we introduce a new tool for cognitive assessment in ID, with the potential for multiple future applications in clinical practice and research.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Medical Research Council (grant number G101400 to K.B.), Newlife Charity for Disabled Children, and Baily Thomas Charitable Trust.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Parent or carer provided written informed consent on behalf of participants under the age of 16. Ethical approval for the CALM study was granted by the National Health Service (NHS) Health Research Authority NRES Committee East of England, REC approval reference 13/EE/0157, IRAS 127675. Ethical approval for the BINGO study was granted by the NHS Health Research Authority NRES Committee East of England, REC approval; reference 11/EE/0330, IRAS 83633All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding authors upon reasonable request.